992
Views
39
CrossRef citations to date
0
Altmetric
Review

An updated patent review of p38 MAP kinase inhibitors (2014-2019)

, , &
Pages 453-466 | Received 24 Jan 2020, Accepted 24 Mar 2020, Published online: 20 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Valentin R Wydra, Raphael B Ditzinger, Nico J Seidler, Frederik W Hacker & Stefan A Laufer. (2023) A patent review of MAPK inhibitors (2018 – present). Expert Opinion on Therapeutic Patents 33:6, pages 421-444.
Read now
Jessica R Thorpe, Rachel A Wilson, Sam Mesiano & Charles J Malemud. (2022) Tofacitinib Inhibits STAT Phosphorylation and Matrix Metalloproteinase-3, -9 and -13 Production by C28/I2 Human Juvenile Chondrocytes. Open Access Rheumatology: Research and Reviews 14, pages 195-209.
Read now

Articles from other publishers (37)

Shamus P. Keeler, Kangyun Wu, Yong Zhang, Dailing Mao, Ming Li, Courtney A. Iberg, Stephen R. Austin, Samuel A. Glaser, Jennifer Yantis, Stephanie Podgorny, Steven L. Brody, Joshua R. Chartock, Zhenfu Han, Derek E. Byers, Arthur G. Romero & Michael J. Holtzman. (2023) A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production. American Journal of Physiology-Lung Cellular and Molecular Physiology 325:6, pages L726-L740.
Crossref
Joan Pous, Blazej Baginski, Pau Martin-Malpartida, Lorena González, Margherita Scarpa, Eric Aragon, Lidia Ruiz, Rebeca A. Mees, Javier Iglesias-Fernández, Modesto Orozco, Angel R. Nebreda & Maria J. Macias. (2023) Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38α. Nature Communications 14:1.
Crossref
Kunyu Li, Leiming You, Jianhua Zhen, Guangrui Huang, Ting Wang, Yanan Cai, Yunan Zhang & Anlong Xu. (2023) Integrated analyses of transcriptomics and network pharmacology reveal leukocyte characteristics and functional changes in subthreshold depression, elucidating the curative mechanism of Danzhi Xiaoyao powder. Journal of Traditional Chinese Medical Sciences.
Crossref
Lorena González, Lucía Díaz, Joan Pous, Blazej Baginski, Anna Duran-Corbera, Margherita Scarpa, Isabelle Brun-Heath, Ana Igea, Pau Martin-Malpartida, Lidia Ruiz, Chiara Pallara, Mauricio Esguerra, Francesco Colizzi, Cristina Mayor-Ruiz, Ricardo M. Biondi, Robert Soliva, Maria J. Macias, Modesto Orozco & Angel R. Nebreda. (2023) Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway. Nature Communications 14:1.
Crossref
Melissa Chassé & Neil Vasdev. (2023) Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [ 11 C]Talmapimod: Effects of Drug Efflux and Sex Differences . ACS Chemical Neuroscience 14:11, pages 2193-2200.
Crossref
Mehdi Valipour. (2023) Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS‐CoV ‐2‐induced CNS complications . Phytotherapy Research.
Crossref
Choudhary Aasiya, Khandekar Mangala, Bagul Chandrakant, Amol Muthal & Ravindra Kulkarni. (2022) Investigation of structure–activity relationship: In silico studies of [1, 2, 4]triazolo[4, 3-a]pyridine ureas as P38 kinase inhibitors. Structural Chemistry 34:3, pages 915-929.
Crossref
Ning Ding, Huiqing Li, Zengzhen Zhang & Haiyan Jia. (2023) Inhibition of importin-7 attenuates ventilator-induced lung injury by targeting nuclear translocation of p38. Inflammation Research 72:5, pages 971-988.
Crossref
Zhiqi Li, Meilin Chen, Zhaoyi Wang, Qiqi Fan, Zili Lin, Xiaoyu Tao, Jiarui Wu, Zhenquan Liu, Ruichao Lin & Chongjun Zhao. (2023) Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis. Bone & Joint Research 12:2, pages 91-102.
Crossref
Mónica Cubillos-Rojas, Guillem Loren, Yusuf Z. Hakim, Xavier Verdaguer, Antoni Riera & Angel R. Nebreda. (2023) Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α. Cancers 15:3, pages 611.
Crossref
Per‐Johan Jakobsson, Luke Robertson, Janika Welzel, Mingshu Zhang, Yang Zhihua, Gao Kaixin, Huang Runyue, Wen Zehuai, Marina Korotkova & Ulf Göransson. (2022) Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis. Journal of Internal Medicine 292:5, pages 745-763.
Crossref
Nathália Grave, Thamiris Becker Scheffel, Fernanda Fernandes Cruz, Liliana Rockenbach, Márcia Inês Goettert, Stefan Laufer & Fernanda Bueno Morrone. (2022) The functional role of p38 MAPK pathway in malignant brain tumors. Frontiers in Pharmacology 13.
Crossref
Utid Suriya, Panupong Mahalapbutr & Thanyada Rungrotmongkol. (2022) Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site. Pharmaceutics 14:7, pages 1461.
Crossref
C.K. Matthew Heng, Nechama Gilad, Ilona Darlyuk-Saadon, W.S. Fred Wong & David Engelberg. (2022) Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy?. Pharmacology & Therapeutics 235, pages 108153.
Crossref
Xinjing Guo, Jia Lou, Fazhan Wang, Daoyang Fan & Zhihai Qin. (2022) Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis. Frontiers in Pharmacology 13.
Crossref
Hai Truong Nguyen, Minh-Nhat Ha Truong, Tan Van Le, Nam Tri Vo, Hoang Duc Nguyen & Phuong Hoang Tran. (2022) A New Pathway for the Preparation of Pyrano[2,3- c ]pyrazoles and molecular Docking as Inhibitors of p38 MAP Kinase . ACS Omega 7:20, pages 17432-17443.
Crossref
Jesús Emanuel Brunetti, Verónica Mara Quintana, Luis Alberto Scolaro & Viviana Castilla. (2022) Inhibitors of the p38 cell signaling pathway as antiviral compounds against Junín virus. Archives of Virology 167:3, pages 935-940.
Crossref
Deri Morgan, Kiersten L. Berggren, Colby D. Spiess, Hannah M. Smith, Ajay Tejwani, Scott J. Weir, Christopher E. Lominska, Sufi M. Thomas & Gregory N. Gan. (2021) Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer. Molecular Carcinogenesis 61:2, pages 173-199.
Crossref
Tatu Pantsar, Philipp D. Kaiser, Mark Kudolo, Michael Forster, Ulrich Rothbauer & Stefan A. Laufer. (2022) Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors. Nature Communications 13:1.
Crossref
Ruibin Liu, Neha Verma, Jack A. Henderson, Shaoqi Zhan & Jana Shen. (2022) Profiling MAP kinase cysteines for targeted covalent inhibitor design. RSC Medicinal Chemistry 13:1, pages 54-63.
Crossref
Luyao Wang, Zhiqiang Xia, Wei Tang, Yu Sun, Yingliang Wu, Hang Fai Kwok, Fang Sun & Zhijian Cao. (2022) p38 activation and viral infection. Expert Reviews in Molecular Medicine 24.
Crossref
Mengdie Gong, Mingyan Tu, Hongxia Sun, Lu Li, Lili Zhu, Honglin Li, Zhenjiang Zhao & Shiliang Li. (2021) Design, Synthesis, and Structure–Activity Relationship Study of Potent MAPK11 Inhibitors. Molecules 27:1, pages 203.
Crossref
Misty M. Attwood, Doriano Fabbro, Aleksandr V. Sokolov, Stefan Knapp & Helgi B. Schiöth. (2021) Trends in kinase drug discovery: targets, indications and inhibitor design. Nature Reviews Drug Discovery 20:11, pages 839-861.
Crossref
E. A. Nickoloff-Bybel, L. Festa, O. Meucci & P. J. Gaskill. (2021) Co-receptor signaling in the pathogenesis of neuroHIV. Retrovirology 18:1.
Crossref
Benno Traub, Aileen Roth, Marko Kornmann, Uwe Knippschild & Joachim Bischof. (2021) Stress-activated kinases as therapeutic targets in pancreatic cancer. World Journal of Gastroenterology 27:30, pages 4963-4984.
Crossref
Quentin Miagoux, Vidisha Singh, Dereck de Mézquita, Valerie Chaudru, Mohamed Elati, Elisabeth Petit-Teixeira & Anna Niarakis. (2021) Inference of an Integrative, Executable Network for Rheumatoid Arthritis Combining Data-Driven Machine Learning Approaches and a State-of-the-Art Mechanistic Disease Map. Journal of Personalized Medicine 11:8, pages 785.
Crossref
Thamires R. Machado, Thayná R. Machado & Pedro G. Pascutti. (2021) The p38 MAPK Inhibitors and Their Role in Inflammatory Diseases. ChemistrySelect 6:23, pages 5729-5742.
Crossref
Maria Zena Miranda, Zsuzsanna Lichner, Katalin Szászi & András Kapus. (2021) MRTF: Basic Biology and Role in Kidney Disease. International Journal of Molecular Sciences 22:11, pages 6040.
Crossref
Begoña Canovas & Angel R. Nebreda. (2021) Diversity and versatility of p38 kinase signalling in health and disease. Nature Reviews Molecular Cell Biology 22:5, pages 346-366.
Crossref
Débora Bublitz Anton, Rodrigo Gay Ducati, Luís Fernando Saraiva Macedo Timmers, Stefan Laufer & Márcia Inês Goettert. (2021) A Special View of What Was Almost Forgotten: p38δ MAPK. Cancers 13:9, pages 2077.
Crossref
Jacques Hugon & Claire Paquet. (2021) The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease. International Journal of Molecular Sciences 22:6, pages 3136.
Crossref
Noha A. M. Shendy & Amy N. Abell. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 959 964 .
Noha A. M. Shendy & Amy N. Abell. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 7 .
Ivana Nikolic, Magdalena Leiva & Guadalupe Sabio. (2020) The role of stress kinases in metabolic disease. Nature Reviews Endocrinology 16:12, pages 697-716.
Crossref
Benjamin Lai, Chien-Hsiang Wu & Jenn-Haung Lai. (2020) Activation of c-Jun N-Terminal Kinase, a Potential Therapeutic Target in Autoimmune Arthritis. Cells 9:11, pages 2466.
Crossref
Olga Roche, Diego M. Fernández-Aroca, Elena Arconada-Luque, Natalia García-Flores, Liliana F. Mellor, María José Ruiz-Hidalgo & Ricardo Sánchez-Prieto. (2020) p38β and Cancer: The Beginning of the Road. International Journal of Molecular Sciences 21:20, pages 7524.
Crossref
Galia Maik-Rachline, Lucia Lifshits & Rony Seger. (2020) Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation. International Journal of Molecular Sciences 21:17, pages 6102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.